The shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) started off the last trading session with the price of $12.15 while closing the day with the price of $12.5. The shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) Rise 2.88% with the Gain of 0.35 points.
The shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) traded with the day volume of 1.36 Million shares whereas its average trading volume is 757.25 Million.
While analyzing the past performance of the stock we can see that the shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) Gain 5.49% in the last week while rising 27.55% in the last month. Past quarter performance shows the green light with 43.68%. The semi-annual and annual performance shows -3.1% and -46.12% respectively.
Some critical values of the shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) to be discussed here are: the beta which shows the value at 3.64 while Average True Range of Coherus Biosciences, Inc. (NASDAQ:CHRS) demonstrate the value at 0.93. The weekly and monthly volatility of the shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) are indicated at 7.20% and 9.12%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 64.
While studying the financial position of the shares of Coherus Biosciences, Inc. (NASDAQ:CHRS), we can see that the Market capitalization of the company is at 730.75 Million. The shares outstanding for the company is 58.46 Million and the shares float stands at 52.78 Million. The income of the company stand at -238200000 while the sales stand at 1.6 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -4.55, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 456.72, the Return on Asset ROA stood at -1.267 and the Return on Equity ROE depicted at -4.803 while Return on Investment ROI is at -1.74.
La Jolla Pharmaceutical Co. (NASDAQ:LJPC)
La Jolla Pharmaceutical Co. (NASDAQ:LJPC) started its previous trading session at $29.96 and closed at $29.45 showing a Fell of -1.9 Percent.
The Company traded with an average Volume of 596.91 Million whereas, its Day Volume stood at 1.35 Million.
Looking at the performance of the stock, La Jolla Pharmaceutical Co. (NASDAQ:LJPC) Loss -12.59% in the last week in its shares price and -10.02% in the last month. Quarterly performance shows a green of 10.76 Percent while Semi-Annual and Annual performances shows a -6.15 and -15.3 percent respectively.
Beta for La Jolla Pharmaceutical Co. (NASDAQ:LJPC) stands at 1.32 while the ATR (average true range) is at 2.14. The Stock’s Weekly and Monthly Volatility is 8.04% and 6.31% respectively showing a RSI value of 42.42.
While studying the financial position of the shares of La Jolla Pharmaceutical Co. (NASDAQ:LJPC), we can see that the Market capitalization of the company is at 664.69 Million. The shares outstanding for the company is 22.57 Million and the shares float stands at 20.69 Million.
The Company generated an income of -114800000 and the sales of 0 in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-5.4 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 0 respectively.
The Return on Assets stands at -0.811, ROE shows a value of -0.949 and ROI for La Jolla Pharmaceutical Co. (NASDAQ:LJPC) is 0 as of Trailing Twelve Months period.
